Pressure BioSciences Inc logo

Pressure BioSciences Inc

NEW
OTCPK:PBIO (USA)  
$ 0.00020 -0.00050 (-71.43%) 07:08 PM EST
At Loss
Market Cap:
$ 8.00K
Enterprise V:
$ 29.19M
Volume:
5.00K
Avg Vol (2M):
19.66K
Trade In:
Volume:
5.00K
At Loss
Avg Vol (2M):
19.66K

Business Description

Pressure BioSciences Inc logo
Pressure BioSciences Inc
NAICS : 339112 SIC : 3841
ISIN : US74112E2081
Description
Pressure BioSciences Inc is engaged in the healthcare division. The firm is a leader in the development & sale of enabling, pressure-based platform solutions for the world-wide life sciences industry. The company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels. The company is also the distributor of the Constant Systems (CS) cell disruption equipment, parts, and consumables. Its products include Barocyclers, External Pressure Calibration Device Kits, MicroTubes, HUB High-Pressure Generators, and Accessories.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
0.19
9-Day RSI
6.35
14-Day RSI
20.98
6-1 Month Momentum %
140
12-1 Month Momentum %
200

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin %
-296.39
OCF Margin %
-296.12
Name Current Vs Industry Vs History
EV-to-EBIT
-1.82
EV-to-EBITDA
-1.85
EV-to-Revenue
19.51
EV-to-FCF
-6.58
Earnings Yield (Greenblatt) %
-54.95
FCF Yield %
-55425

Financials

PBIO's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:PBIO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Pressure BioSciences Inc Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.496
EPS (TTM) ($) -0.96
Beta -0.6352
3-Year Sharpe Ratio 0.68
3-Year Sortino Ratio 2.25
Volatility % 656.44
14-Day RSI 20.98
14-Day ATR ($) 0.000118
20-Day SMA ($) 0.00085
12-1 Month Momentum % 200
52-Week Range ($) 0.0001 - 0.2
Shares Outstanding (Mil) 40.97

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Pressure BioSciences Inc Filings

Filing Date Document Date Form
No Filing Data

Pressure BioSciences Inc Stock Events

Financials Calendars
Event Date Price ($)
0.033333:1 Stock Split 2017-06-05 6.60 (-4.35%)
Show
Entries

Pressure BioSciences Inc Frequently Asked Questions

What is Pressure BioSciences Inc(PBIO)'s stock price today?
The current price of PBIO is $0.00. The 52 week high of PBIO is $0.20 and 52 week low is $0.00.
When is next earnings date of Pressure BioSciences Inc(PBIO)?
The next earnings date of Pressure BioSciences Inc(PBIO) is .
Does Pressure BioSciences Inc(PBIO) pay dividends? If so, how much?
Pressure BioSciences Inc(PBIO) does not pay dividend.

Guru Commentaries on OTCPK:PBIO

No articles.

Press Release

Subject Date
Pressure BioSciences' BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) Technologies 2024-01-04
Pressure BioSciences' Celebrates Second Groundbreaking Article Published This Month on its Transformative, Patented UltraShear Technology Processing Platform 2023-12-21
Pressure BioSciences' UltraShear Platform Maintains Nutritional, Sensory, and Other Important Qualities of Liquid Foods While Inactivating Foodborne Bacterial Spores 2023-12-12
Pressure BioSciences and Veterans Service Team Launch UltraShear Best-in-Class Nano-CBD Topical Spray - MMA Champ Cat Zingano Now Official VST Ambassador 2023-12-01
Pressure BioSciences, Inc. to Discuss Third Quarter 2023 Financial Results and Provide Business Update 2023-11-20
Pressure BioSciences Announces Exclusive Distribution Agreement with One of India's Premier Distributors of Lab Automation, Instruments, and Consumables 2023-10-18
Pressure BioSciences Continues Expansion of IP Portfolio of Revolutionary UltraShear Technology with Award of First Canadian Patent 2023-10-10
Pressure BioSciences' Partner Veterans Service Team Increases Existing Purchase Order by 10X for Bottles of UltraShear Nano-CBD Topical Spray, Effective Immediately 2023-09-22
Pressure BioSciences Fulfillment of UltraShear Nano-CBD Orders is Underway; Customer Shipments Begin First Week of October 2023-09-21
Pressure BioSciences' BaroFold Technology Achieves Pivotal Equipment Sale and Begins Scale-up in Service to Leading Global Contract Devt. & Mfg. Organization 2023-09-08
10/Page

Articles on Pressure BioSciences Inc

No articles.

Headlines

See More
  • 1
No news.
  • 1